Cortical Demyelination in PML and MS
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Cortical demyelination now appears to be an important pathologic substrate for functional deficits in MS and PML yet the pathology differs from that in the white matter. What is our current understanding? Dr. Richard Ransohoff, the Director of the Neuroinflammation Research Center at the Lerner Research Institue of the Cleveland Clinic joins host Dr. Leslie Lundt to discuss his work in this exciting branch of neurology.
Overview
Cortical demyelination now appears to be an important pathologic substrate for functional deficits in MS and PML yet the pathology differs from that in the white matter. What is our current understanding? Dr. Richard Ransohoff, the Director of the Neuroinflammation Research Center at the Lerner Research Institue of the Cleveland Clinic joins host Dr. Leslie Lundt to discuss his work in this exciting branch of neurology.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Pulmonary Hypertension Management: Practice Trends and Updates
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?